Literature DB >> 23017199

Characterization of Mycobacterium orygis.

Nicolaas C Gey van Pittius, Paul D van Helden, Robin M Warren.   

Abstract

Entities:  

Mesh:

Year:  2012        PMID: 23017199      PMCID: PMC3471637          DOI: 10.3201/eid1810.120569

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


× No keyword cloud information.
To the Editor: In a recently published study, van Ingen et al. () described the molecular characterization and phylogenetic position of the oryx bacillus, a member of the Mycobacterium tuberculosis complex, and proposed a long overdue name for the organism: Mycobacterium orygis. The authors described oryx bacillus as a separate taxon; the aim was for this description to be used in the future to identify the subspecies. Thus, we thought it pertinent to provide additional information that would be useful in speciating isolates of the oryx bacillus. In a recent study, we genotyped an isolate of oryx bacillus obtained from an African buffalo in South Africa (). This isolate was typed by using 16S rDNA, M. tuberculosis complex–specific multiplex-PCR, regions-of-difference analyses, gyrase B gene single nucleotide polymorphism (SNP) analysis, spoligotyping, and mycobacterial interspersed repetitive units–variable number tandem repeat typing. We showed that, in addition to the markers described by van Ingen et al. (), regions of difference 701 and 702 were also intact in M. orygis. In addition, van Ingen et al. identified the Rv2042 GGC mutation as a novel, useful genetic marker to identify M. orygis. However, such a marker already exists in the form of the very specific gyrB G to A SNP at position 1113, which was described by Huard et al. (). On its own, SNP detection in the gyrB gene allows differentiation of at least 6 of the 9 M. tuberculosis complex species from each other (M. canettii, M. tuberculosis, M. orygis, M. microti, M. caprae, and M. bovis) (). Thus, the SNP at position 1113 is more useful than the Rv204238 mutation as a novel and distinct genetic marker to identify M. orygis. Apart from this, we found that the sequence type (ST) 587 was not the only spoligotype specific for M. orygis. In our study, the variant type ST701 (annotated as M. africanum in the spolDB4 database) () is also an M. orygis–specific type and exactly matches that of a previous isolate of the oryx bacillus (SB0319) from the M. bovis spoligotype database (). This spoligotype differs from ST587 by the presence of spacer 18, and the spoligotype was not found in the extensive sample set of van Ingen et al. ().
  4 in total

1.  Novel genetic polymorphisms that further delineate the phylogeny of the Mycobacterium tuberculosis complex.

Authors:  Richard C Huard; Michel Fabre; Petra de Haas; Luiz Claudio Oliveira Lazzarini; Dick van Soolingen; Debby Cousins; John L Ho
Journal:  J Bacteriol       Date:  2006-06       Impact factor: 3.490

2.  Infection of African buffalo (Syncerus caffer) by oryx bacillus, a rare member of the antelope clade of the Mycobacterium tuberculosis complex.

Authors:  Nicolaas C Gey van Pittius; Keith D Perrett; Anita L Michel; Dewald F Keet; Tiny Hlokwe; Elizabeth M Streicher; Robin M Warren; Paul D van Helden
Journal:  J Wildl Dis       Date:  2012-10       Impact factor: 1.535

3.  Characterization of Mycobacterium orygis as M. tuberculosis complex subspecies.

Authors:  Jakko van Ingen; Zeaur Rahim; Arnout Mulder; Martin J Boeree; Roxane Simeone; Roland Brosch; Dick van Soolingen
Journal:  Emerg Infect Dis       Date:  2012-04       Impact factor: 6.883

4.  Mycobacterium tuberculosis complex genetic diversity: mining the fourth international spoligotyping database (SpolDB4) for classification, population genetics and epidemiology.

Authors:  Karine Brudey; Jeffrey R Driscoll; Leen Rigouts; Wolfgang M Prodinger; Andrea Gori; Sahal A Al-Hajoj; Caroline Allix; Liselotte Aristimuño; Jyoti Arora; Viesturs Baumanis; Lothar Binder; Patricia Cafrune; Angel Cataldi; Soonfatt Cheong; Roland Diel; Christopher Ellermeier; Jason T Evans; Maryse Fauville-Dufaux; Séverine Ferdinand; Dario Garcia de Viedma; Carlo Garzelli; Lidia Gazzola; Harrison M Gomes; M Cristina Guttierez; Peter M Hawkey; Paul D van Helden; Gurujaj V Kadival; Barry N Kreiswirth; Kristin Kremer; Milan Kubin; Savita P Kulkarni; Benjamin Liens; Troels Lillebaek; Minh Ly Ho; Carlos Martin; Christian Martin; Igor Mokrousov; Olga Narvskaïa; Yun Fong Ngeow; Ludmilla Naumann; Stefan Niemann; Ida Parwati; Zeaur Rahim; Voahangy Rasolofo-Razanamparany; Tiana Rasolonavalona; M Lucia Rossetti; Sabine Rüsch-Gerdes; Anna Sajduda; Sofia Samper; Igor G Shemyakin; Urvashi B Singh; Akos Somoskovi; Robin A Skuce; Dick van Soolingen; Elisabeth M Streicher; Philip N Suffys; Enrico Tortoli; Tatjana Tracevska; Véronique Vincent; Tommie C Victor; Robin M Warren; Sook Fan Yap; Khadiza Zaman; Françoise Portaels; Nalin Rastogi; Christophe Sola
Journal:  BMC Microbiol       Date:  2006-03-06       Impact factor: 3.605

  4 in total
  5 in total

Review 1.  Microbiological features and clinical relevance of new species of the genus Mycobacterium.

Authors:  Enrico Tortoli
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

Review 2.  Co-evolution of Mycobacterium tuberculosis and Homo sapiens.

Authors:  Daniela Brites; Sebastien Gagneux
Journal:  Immunol Rev       Date:  2015-03       Impact factor: 12.988

3.  Identification of region of difference and H37Rv-related deletion in Mycobacterium tuberculosis complex by structural variant detection and genome assembly.

Authors:  Zhuochong Liu; Zhonghua Jiang; Wei Wu; Xinyi Xu; Yudong Ma; Xiaomei Guo; Senlin Zhang; Qun Sun
Journal:  Front Microbiol       Date:  2022-09-08       Impact factor: 6.064

4.  Characterization of Mycobacterium orygis.

Authors:  Jakko van Ingen; Roland Brosch; Dick van Soolingen
Journal:  Emerg Infect Dis       Date:  2013-03       Impact factor: 6.883

Review 5.  Immunological consequences of strain variation within the Mycobacterium tuberculosis complex.

Authors:  Leopold D Tientcheu; Anastasia Koch; Mthawelenga Ndengane; Genevieve Andoseh; Beate Kampmann; Robert J Wilkinson
Journal:  Eur J Immunol       Date:  2017-02-24       Impact factor: 5.532

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.